TrialAnnals of oncology : official journal of the European Society for Medical Oncology2016

Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1).

M De Santis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.